Be The Match

Be The Match
Name	Be The Match
Type	Nonprofit organization
Founded	1987
Headquarters	Minneapolis, Minnesota
Region served	United States
Purpose	Facilitate bone marrow and hematopoietic cell transplants

Be The Match Be The Match is a nonprofit organization that operates a national bone marrow and hematopoietic cell registry connecting patients with donors and coordinating transplants. It partners with hospitals, research institutions, and international registries to facilitate treatment for blood cancers and genetic disorders. The organization maintains a large database of volunteer donors and cord blood units and supports research, clinical trials, and public education efforts.

History

The registry emerged from collaborations among medical centers such as Mayo Clinic, Fred Hutchinson Cancer Center, Dana–Farber Cancer Institute, and University of Minnesota in the late 20th century, influenced by pioneering transplant work by physicians at Seattle Cancer Care Alliance and researchers associated with National Institutes of Health initiatives. Early developments paralleled advances in HLA typing from laboratories like Johns Hopkins Hospital and coordination models used by World Health Organization networks. Organizational milestones included expansions following partnerships with entities such as American Society of Hematology and integration with international registries like Delete Blood Cancer and registries coordinated through Bone Marrow Donors Worldwide. Legislative and philanthropic support from figures linked to American Red Cross efforts and foundations such as Bill & Melinda Gates Foundation and Robert Wood Johnson Foundation influenced scaling. Over decades the registry adapted to innovations from institutions including Broad Institute, University of Pennsylvania, and Columbia University, aligning with transplant programs at Memorial Sloan Kettering Cancer Center and Cleveland Clinic.

Organization and Governance

The nonprofit structure includes a board drawing expertise from clinical leaders at Stanford Health Care, health policy experts from Kaiser Permanente, and representatives from advocacy groups like Leukemia & Lymphoma Society. Executive decisions reflect input from scientists connected to National Cancer Institute, ethicists with ties to Johns Hopkins Bloomberg School of Public Health, and legal advisors familiar with regulations from U.S. Food and Drug Administration and oversight frameworks in collaboration with Centers for Disease Control and Prevention. Operational partnerships involve logistics providers used by academic medical centers such as Massachusetts General Hospital and cross-border coordination with agencies like European Medicines Agency for international exchanges. Financial oversight and fundraising align with nonprofit practices informed by analyses from Harvard Business School and Stanford Graduate School of Business alumni serving as trustees.

Donor Registry and Matching Process

The registry catalogs HLA profiles using methodologies developed in part at University of Chicago and Yale School of Medicine laboratories, applying algorithms similar to those described in publications from Nature and The New England Journal of Medicine. Donor recruitment campaigns have targeted communities connected to institutions like Howard University and University of Texas MD Anderson Cancer Center to improve representation for patients treated at centers such as University of California, San Francisco and Mount Sinai Health System. Matching workflows integrate data-sharing protocols used by International Society for Stem Cell Research and coordinate courier logistics comparable to those used by United Parcel Service and FedEx for time-sensitive transport. Clinical coordination engages transplant teams at Hospital of the University of Pennsylvania and uses standards promulgated by American Society for Transplantation and Cellular Therapy. Cord blood units are listed in national repositories influenced by models from New York Blood Center and protocols informed by Children's Hospital of Philadelphia.

Research and Clinical Programs

Research programs support clinical trials run with partners like University of North Carolina Lineberger Comprehensive Cancer Center and Johns Hopkins Kimmel Cancer Center, investigating graft-versus-host disease and novel conditioning regimens pioneered at Fred Hutchinson Cancer Research Center and NCI-designated Cancer Centers. Collaborative grants have involved institutions such as Stanford University, MIT, and University College London on genomic matching and cell therapy optimization, with publications in journals like Cell and Lancet Oncology. Programs include data-sharing partnerships with biobanks at Broad Institute and bioinformatics collaborations with groups at Sanger Institute. Clinical outcomes analysis often references multicenter studies including cohorts from Brigham and Women's Hospital and Vanderbilt University Medical Center.

Public Outreach and Fundraising

Outreach campaigns have partnered with celebrities and philanthropic platforms associated with Oprah Winfrey, Ellen DeGeneres, and events tied to NFL charities to boost donor registration. Fundraising strategies leverage connections with foundations such as Ford Foundation and corporate sponsors from United Airlines and Target Corporation to underwrite recruitment and research programs. Community engagement has included collaborations with cultural institutions like Smithsonian Institution and historically Black colleges like Spelman College to address donor diversity. Educational materials and awareness drives reference clinical resources from American Cancer Society and patient advocacy organizations such as Susan G. Komen.

Criticism and Controversies

Critiques have focused on donor representation disparities highlighted by analyses from researchers at Columbia University Mailman School of Public Health and policy commentators from Brookings Institution and Urban Institute. Debates with bioethicists at Georgetown University and clinical researchers at Yale School of Medicine raised questions about consent processes, cost structures compared with programs at National Health Service (England), and transparency concerns noted by watchdogs including ProPublica. Operational controversies involved logistical disputes reminiscent of cases investigated by U.S. Department of Health and Human Services and media coverage from outlets such as The New York Times and Washington Post. Reforms followed recommendations from advisory committees similar to those convened by Institute of Medicine and academic audits by groups at University of Michigan.

Category:Bone marrow transplantation organizations